Johanna Kela

Johanna Kela is a Senior Scientist at Orion Corporation, a position held since January 2003, where responsibilities include serving as study director for nonclinical drug development projects focused on chronic pain and exploring novel drug target ideas. Previous roles at Orion Corporation include Team Leader for in vivo laboratory operations related to CNS and a Research Scientist managing a COMT inhibitor project in preclinical settings. Prior to joining Orion Corporation, Johanna Kela undertook a Ph.D. at Karolinska Institutet, conducting research on gene silencing using in vitro and in vivo techniques. Educationally, Johanna Kela earned a Master of Science in Biochemistry from the University of Oulu between 1992 and 1999.